Pranav Mody, director at J B Chemicals & Pharmaceuticals Ltd, says the company's deals with Johnson & Johnson and Dr Reddy's would result in Rs 500 crore for JB Chem which it will use for growth plans. He says the company will stay in the pharma space and will grow the ROW and domestic business.